Paper24345865
Influence of Polyethylene Glycol Lipid Desorption Rates on Pharmacokinetics and Pharmacodynamics of siRNA Lipid Nanoparticles.
Mui BL and 15 others. Mol Ther Nucleic Acids, 2013. Cited by 427 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Influence of Polyethylene Glycol Lipid Desorption Rates on Pharmacokinetics and Pharmacodynamics of siRNA Lipid Nanoparticles. Papers, record 24345865. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/24345865
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Influence of Polyethylene Glycol Lipid Desorption Rates on Pharmacokinetics and Pharmacodynamics of siRNA Lipid Nanoparticles.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References26
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 19259063 | Development of lipidoid-siRNA formulations for systemic delivery to the liver. | Mol Ther | 2009 | https://conductscience.org/library/papers/19259063 | PubMed |
| 2 | 15525796 | Immunogenicity and rapid blood clearance of liposomes containing polyethylene glycol-lipid conjugates and nucleic Acid. | J Pharmacol Exp Ther | 2005 | https://conductscience.org/library/papers/15525796 | PubMed |
| 3 | 18438401 | A combinatorial library of lipid-like materials for delivery of RNAi therapeutics. | Nat Biotechnol | 2008 | https://conductscience.org/library/papers/18438401 | PubMed |
| 4 | 7918562 | Factors influencing the retention and chemical stability of poly(ethylene glycol)-lipid conjugates incorporated into large unilamellar vesicles. | Biochim Biophys Acta | 1994 | https://conductscience.org/library/papers/7918562 | PubMed |
| 5 | 22962627 | Lipid Nanoparticles Containing siRNA Synthesized by Microfluidic Mixing Exhibit an Electron-Dense Nanostructured Core. | J Phys Chem C Nanomater Interfaces | 2012 | https://conductscience.org/library/papers/22962627 | PubMed |
| 6 | 16565705 | RNAi-mediated gene silencing in non-human primates. | Nature | 2006 | https://conductscience.org/library/papers/16565705 | PubMed |
| 7 | 20081866 | Rational design of cationic lipids for siRNA delivery. | Nat Biotechnol | 2010 | https://conductscience.org/library/papers/20081866 | PubMed |
| 8 | 17541417 | Interfering with disease: a progress report on siRNA-based therapeutics. | Nat Rev Drug Discov | 2007 | https://conductscience.org/library/papers/17541417 | PubMed |
| 9 | 23358650 | First-in-humans trial of an RNA interference therapeutic targeting VEGF and KSP in cancer patients with liver involvement. | Cancer Discov | 2013 | https://conductscience.org/library/papers/23358650 | PubMed |
| 10 | 16603272 | Synthesis and characterization of novel poly(ethylene glycol)-lipid conjugates suitable for use in drug delivery. | J Control Release | 2006 | https://conductscience.org/library/papers/16603272 | PubMed |
| 11 | 19209940 | Molecular mechanism of apolipoprotein E binding to lipoprotein particles. | Biochemistry | 2009 | https://conductscience.org/library/papers/19209940 | PubMed |
| 12 | 20461061 | Targeted delivery of RNAi therapeutics with endogenous and exogenous ligand-based mechanisms. | Mol Ther | 2010 | https://conductscience.org/library/papers/20461061 | PubMed |
| 13 | 11750259 | Characterization of the inhibitory effect of PEG-lipid conjugates on the intracellular delivery of plasmid and antisense DNA mediated by cationic lipid liposomes. | Biochim Biophys Acta | 2002 | https://conductscience.org/library/papers/11750259 | PubMed |
| 14 | 11342155 | Efficient encapsulation of antisense oligonucleotides in lipid vesicles using ionizable aminolipids: formation of novel small multilamellar vesicle structures. | Biochim Biophys Acta | 2001 | https://conductscience.org/library/papers/11342155 | PubMed |
| 15 | 7820455 | Immunoliposomes and PEGylated immunoliposomes: possible use for targeted delivery of imaging agents. | Immunomethods | 1994 | https://conductscience.org/library/papers/7820455 | PubMed |
| 16 | 23799535 | Biodegradable lipids enabling rapidly eliminated lipid nanoparticles for systemic delivery of RNAi therapeutics. | Mol Ther | 2013 | https://conductscience.org/library/papers/23799535 | PubMed |
| 17 | 22782619 | Maximizing the potency of siRNA lipid nanoparticles for hepatic gene silencing in vivo. | Angew Chem Int Ed Engl | 2012 | https://conductscience.org/library/papers/22782619 | PubMed |
| 18 | 3297153 | Mechanisms and consequences of cellular cholesterol exchange and transfer. | Biochim Biophys Acta | 1987 | https://conductscience.org/library/papers/3297153 | PubMed |
| 19 | 17200713 | Atherogenic remnant lipoproteins: role for proteoglycans in trapping, transferring, and internalizing. | J Clin Invest | 2007 | https://conductscience.org/library/papers/17200713 | PubMed |
| 20 | 23984729 | Safety and efficacy of RNAi therapy for transthyretin amyloidosis. | N Engl J Med | 2013 | https://conductscience.org/library/papers/23984729 | PubMed |
Cited by239
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 427 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42975285 | Poly(acrylamido) PEG-Alternative Lipids Rescue mRNA Efficacy during Repeated Dosing and Enhance Immune Cell Delivery. | ACS Nano | 2026 | https://conductscience.org/library/papers/42975285 | PubMed |
| 42916086 | Boosting Ligand-Mediated Hepatic mRNA Delivery and Gene Editing Through Coordinated Pairing of Polyethylene Glycol-Modified Lipids. | ACS Nano | 2026 | https://conductscience.org/library/papers/42916086 | PubMed |
| 42818376 | A multiscale modeling framework for transport of PEGy-lated lipid nanoparticle through the extracellular matrix. | bioRxiv | 2026 | https://conductscience.org/library/papers/42818376 | PubMed |
| 42761399 | In vivo CAR T-cell generation: delivery platforms, clinical progress, and translational barriers. | Front Immunol | 2026 | https://conductscience.org/library/papers/42761399 | PubMed |
| 42751674 | PEG-lipid shedding and biodistribution are shaped by nanocarrier morphology and lipid chemistry. | Cell Biomater | 2026 | https://conductscience.org/library/papers/42751674 | PubMed |
| 42729701 | Engineering tolerogenic mRNA-LNPs for allergen-specific immune reprogramming in pollen allergy. | Mater Today Bio | 2026 | https://conductscience.org/library/papers/42729701 | PubMed |
| 42723396 | Chemical and Biological Determinants of PEG-Lipid Shedding From Therapeutic Nanoparticles. | Small | 2026 | https://conductscience.org/library/papers/42723396 | PubMed |
| 42688794 | Focused Ultrasound is Poised to Take Non-Viral Gene Therapies to the Blood-Brain Barrier - and Beyond. | Cell Biomater | 2026 | https://conductscience.org/library/papers/42688794 | PubMed |
| 42677161 | Overcoming hepatic tropism: Precision engineering of lipid nanoparticles for extrahepatic RNA delivery. | Mater Today Bio | 2026 | https://conductscience.org/library/papers/42677161 | PubMed |
| 42568897 | Physiologically based pharmacokinetic modeling of mRNA therapeutics: A multiscale framework for LNP and antibody trafficking in mice. | Mol Ther Nucleic Acids | 2026 | https://conductscience.org/library/papers/42568897 | PubMed |
| 42557300 | Engineered lipid nanoparticles for in vivo and durable editing of haematopoietic stem cells within humanized mice. | Nat Biomed Eng | 2026 | https://conductscience.org/library/papers/42557300 | PubMed |
| 42516173 | Quantitative recovery of methoxy poly(ethylene glycol) and PEGylated nanosystems from complex biological matrices. | Nanoscale Adv | 2026 | https://conductscience.org/library/papers/42516173 | PubMed |
| 42363593 | Membrane environment sets the functional pKa of ionizable lipids. | Biophys J | 2026 | https://conductscience.org/library/papers/42363593 | PubMed |
| 42326077 | Delivering the future of immunotherapy: A state-of-the-art review of gene editing in immune cells with lipid nanoparticles. | Mater Today Bio | 2026 | https://conductscience.org/library/papers/42326077 | PubMed |
| 42326074 | Identification of a cell subpopulation with different response to lipid nanoparticles and effect of protein corona on uptake and transfection. | Mater Today Bio | 2026 | https://conductscience.org/library/papers/42326074 | PubMed |
| 42285973 | Influence of protein aggregates, extracellular vesicles, and lipoprotein fusion on ionizable lipid nanoparticles protein corona analysis. | Nat Commun | 2026 | https://conductscience.org/library/papers/42285973 | PubMed |
| 42272984 | Tissue-specific gene delivery approaches. | Bioeng Transl Med | 2026 | https://conductscience.org/library/papers/42272984 | PubMed |
| 42198337 | Delivery of mRNA Therapeutics Beyond Infectious Diseases: Design Innovations and Applications in Oncology, Cardiovascular, and Rare Genetic Diseases. | Pharmaceuticals (Basel) | 2026 | https://conductscience.org/library/papers/42198337 | PubMed |
| 42193329 | Effect of Short-Anchored PEGylated Lipids on Lipid Nanoparticle Characterization Profiles, Stability, and Efficacy. | Biomedicines | 2026 | https://conductscience.org/library/papers/42193329 | PubMed |
| 42085855 | Engineering lipid nanoparticle surface hydrophobicity to modulate nano-bio interface and enable tissue-selective mRNA delivery. | Biomaterials | 2026 | https://conductscience.org/library/papers/42085855 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/24345865
GET https://conductscience.org/api/papers/v1/24345865/references?page=2